These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
166 related articles for article (PubMed ID: 7490559)
1. Inhibition of 5 alpha-reductase in genital skin fibroblasts and prostate tissue by dietary lignans and isoflavonoids. Evans BA; Griffiths K; Morton MS J Endocrinol; 1995 Nov; 147(2):295-302. PubMed ID: 7490559 [TBL] [Abstract][Full Text] [Related]
2. Inhibitory effects of isoflavonoids on rat prostate testosterone 5α-reductase. Bae M; Woo M; Kusuma IW; Arung ET; Yang CH; Kim YU J Acupunct Meridian Stud; 2012 Dec; 5(6):319-22. PubMed ID: 23265084 [TBL] [Abstract][Full Text] [Related]
3. Comparison of flavonoids and isoflavonoids to inhibit rat and human 11β-hydroxysteroid dehydrogenase 1 and 2. Zhu Q; Ge F; Dong Y; Sun W; Wang Z; Shan Y; Chen R; Sun J; Ge RS Steroids; 2018 Apr; 132():25-32. PubMed ID: 29425740 [TBL] [Abstract][Full Text] [Related]
4. Inhibition of mouse and human CYP 1A- and 2E1-dependent substrate metabolism by the isoflavonoids genistein and equol. Helsby NA; Chipman JK; Gescher A; Kerr D Food Chem Toxicol; 1998 May; 36(5):375-82. PubMed ID: 9662412 [TBL] [Abstract][Full Text] [Related]
5. Regulation of c-fos transcription by chemopreventive isoflavonoids and lignans in MDA-MB-468 breast cancer cells. Schultze-Mosgau MH; Dale IL; Gant TW; Chipman JK; Kerr DJ; Gescher A Eur J Cancer; 1998 Aug; 34(9):1425-31. PubMed ID: 9849427 [TBL] [Abstract][Full Text] [Related]
6. Comparative study of concentration of isoflavones and lignans in plasma and prostatic tissues of normal control and benign prostatic hyperplasia. Hong SJ; Kim SI; Kwon SM; Lee JR; Chung BC Yonsei Med J; 2002 Apr; 43(2):236-41. PubMed ID: 11971218 [TBL] [Abstract][Full Text] [Related]
8. Soy isoflavonoid equol modulates the growth of benign and malignant prostatic epithelial cells in vitro. Hedlund TE; Johannes WU; Miller GJ Prostate; 2003 Jan; 54(1):68-78. PubMed ID: 12481257 [TBL] [Abstract][Full Text] [Related]
9. Variation in steroid 5 alpha-reductase activity in cloned human skin fibroblasts. Shift in phenotypic expression from high to low activity upon subcloning. Griffin JE; Allman DR; Durrant JL; Wilson JD J Biol Chem; 1981 Apr; 256(8):3662-6. PubMed ID: 6938516 [TBL] [Abstract][Full Text] [Related]
10. The distribution of 5 alpha-reductase and 3 alpha(beta)-hydroxysteroid dehydrogenase activities in the hyperplastic human prostate gland. Habib FK; Beynon L; Chisholm GD; Busuttil A Steroids; 1983 Jan; 41(1):41-53. PubMed ID: 6197780 [TBL] [Abstract][Full Text] [Related]
11. Isotope dilution gas chromatographic-mass spectrometric method for the determination of lignans and isoflavonoids in human urine, including identification of genistein. Adlercreutz H; Fotsis T; Bannwart C; Wähälä K; Brunow G; Hase T Clin Chim Acta; 1991 Jul; 199(3):263-78. PubMed ID: 1663006 [TBL] [Abstract][Full Text] [Related]
12. Determination of lignans and isoflavonoids in human female plasma following dietary supplementation. Morton MS; Wilcox G; Wahlqvist ML; Griffiths K J Endocrinol; 1994 Aug; 142(2):251-9. PubMed ID: 7930998 [TBL] [Abstract][Full Text] [Related]
13. Measurement and metabolism of isoflavonoids and lignans in the human male. Morton MS; Matos-Ferreira A; Abranches-Monteiro L; Correia R; Blacklock N; Chan PS; Cheng C; Lloyd S; Chieh-ping W; Griffiths K Cancer Lett; 1997 Mar; 114(1-2):145-51. PubMed ID: 9103275 [TBL] [Abstract][Full Text] [Related]
14. Lignans and isoflavonoids in plasma and prostatic fluid in men: samples from Portugal, Hong Kong, and the United Kingdom. Morton MS; Chan PS; Cheng C; Blacklock N; Matos-Ferreira A; Abranches-Monteiro L; Correia R; Lloyd S; Griffiths K Prostate; 1997 Jul; 32(2):122-8. PubMed ID: 9215400 [TBL] [Abstract][Full Text] [Related]
15. LY191704: a selective, nonsteroidal inhibitor of human steroid 5 alpha-reductase type 1. Hirsch KS; Jones CD; Audia JE; Andersson S; McQuaid L; Stamm NB; Neubauer BL; Pennington P; Toomey RE; Russell DW Proc Natl Acad Sci U S A; 1993 Jun; 90(11):5277-81. PubMed ID: 8389478 [TBL] [Abstract][Full Text] [Related]
16. Androgen inactivation in human lung fibroblasts: variations in levels of 17 beta-hydroxysteroid dehydrogenase type 2 and 5 alpha-reductase activity compatible with androgen inactivation. Provost PR; Blomquist CH; Drolet R; Flamand N; Tremblay Y J Clin Endocrinol Metab; 2002 Aug; 87(8):3883-92. PubMed ID: 12161528 [TBL] [Abstract][Full Text] [Related]
17. Effect of aging on kinetic parameters of 3 alpha(beta)-hydroxysteroid oxidoreductases in epithelium and stroma of human normal and hyperplastic prostate. Tunn S; Haumann R; Hey J; Flüchter SH; Krieg M J Clin Endocrinol Metab; 1990 Sep; 71(3):732-9. PubMed ID: 1697599 [TBL] [Abstract][Full Text] [Related]
18. Increased ratio of 5 alpha-reductase: 3 alpha (beta)-hydroxysteroid dehydrogenase activities in the hyperplastic human prostate. Bruchovsky N; Lieskovsky G J Endocrinol; 1979 Mar; 80(3):289-301. PubMed ID: 86594 [TBL] [Abstract][Full Text] [Related]
19. Soy isoflavonoids exhibit in vitro biological activities of loop diuretics. Martínez RM; Giménez I; Lou JM; Mayoral JA; Alda JO Am J Clin Nutr; 1998 Dec; 68(6 Suppl):1354S-1357S. PubMed ID: 9848498 [TBL] [Abstract][Full Text] [Related]
20. Androgen 5 alpha-reductase and 3 alpha-hydroxysteroid dehydrogenase activities in ventral prostate epithelial and stromal cells from immature and mature rats. Orlowski J; Bird CE; Clark AF J Endocrinol; 1983 Oct; 99(1):131-9. PubMed ID: 6579162 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]